Fig. 2.

Proposal of a clinical algorithm to screen competitive athletes recovering from SARS-CoV-2 infection before their return-to-play.

*The test is indicated on a case-by-case decision, based on clinical symptoms, individual risk profile and clinical course of Covid-19 infection.

^New pre-participation evaluation should be performed according to national modalities and recommendations.

§ in case of abnormal 12‑lead resting ECG, uncommon ventricular arrhythmias or cardiac symptoms.